StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
SRZN

Surrozen, Inc.

SRZN Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$21.78
+0.95 +4.56%

Key statistics

from XBRL data in SEC filings
Market cap
$253M
Revenue (TTM)
$7.49M
Net income (TTM)
-$343M
EPS (TTM)
$-36.59
P/E ratio
Dividend yield
Free cash flow
-$30.4M
Cash
$107M
Total assets
$121M
Gross margin
52-week range
$9.03 – $35.00

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results May 14, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 23, 2026 8-K Results of operations (earnings release) Mar 23, 2026 8-K Director or officer change Jan 30, 2026 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Results of operations (earnings release); Director or officer change Nov 7, 2025 8-K Terminated a material agreement Oct 17, 2025 8-K Entered a material agreement Aug 29, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Results of operations (earnings release) Aug 8, 2025 8-K Shareholder vote results May 15, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release) May 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change Mar 28, 2025 8-K Regulation FD disclosure Mar 24, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Entered a material agreement Oct 2, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Director or officer change Jul 1, 2024 8-K Shareholder vote results Jun 7, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 10-K Fiscal year ended 2023-12-31 Apr 10, 2024 8-K Entered a material agreement; Unregistered sale of equity Apr 2, 2024 8-K Regulation FD disclosure Apr 1, 2024 8-K Director or officer change Feb 7, 2024 8-K Other events Jan 18, 2024 8-K Amended charter or bylaws Dec 13, 2023 8-K Shareholder vote results; Other events Dec 11, 2023 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Results of operations (earnings release) Nov 8, 2023 8-K Amended charter or bylaws Oct 13, 2023 10-Q Quarter ended 2023-06-30 Aug 9, 2023 8-K Results of operations (earnings release) Aug 9, 2023